Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Zhongtai: Still optimistic about technology and gold in the medium term, but need to pay attention to the sustainability of liquidity overflow.

China Securities Co., Ltd.: No worries about the increase in sodium battery prices next year, and the lithium carbonate price increase expectations accelerating process.

Hong Kong stock concept tracking | Large-scale, intelligent body procurement welcomes policy dividends Token consumption is expected to continue to grow at a high speed (with concept stocks)
Zhongtai: Still optimistic about technology and gold in the medium term, but need to pay attention to the sustainability of liquidity overflow.

China Securities Co., Ltd.: No worries about the increase in sodium battery prices next year, and the lithium carbonate price increase expectations accelerating process.

Hong Kong stock concept tracking | Large-scale, intelligent body procurement welcomes policy dividends Token consumption is expected to continue to grow at a high speed (with concept stocks)

RECOMMEND

DeepSeek’s $10 Billion Valuation Financing Rumor And Four Layers Of Logical Judgment
21/04/2026

48 Hours Witness AI’s New Battlefield: Alibaba Joins, Tencent Open Sources, Manycore Tech Lists — Has The World Model Reached Its ChatGPT Moment?
21/04/2026

Public Fund Giants Reverse Course With Heavy Hong Kong IPO Cornerstone Allocations Exceeding HK$2.2 Billion Year‑To‑Date
21/04/2026


